A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module

被引:4
|
作者
Paradowska, Dominika [1 ]
Bereza, Krzysztof [2 ]
Sanna, Beatrice [3 ]
Kucharska, Ewa [4 ]
Tomaszewska, Iwona M. [5 ]
Dudkiewicz, Zbigniew [6 ]
Skotnicki, Piotr [7 ]
Bottomley, Andrew [8 ]
Tomaszewski, Krzysztof A. [9 ]
机构
[1] John Paul II Specialist Hosp, Dept Clin Oncol, Krakow, Poland
[2] Jagiellonian Univ, Med Coll, Dept Gynaecol Care, Krakow, Poland
[3] Univ Cagliari, Fac Med & Surg, Monserrato, Italy
[4] Ignatianum Acad, Faulty Educ, Dept Gerontol Geriatr & Social Work, Krakow, Poland
[5] Jagiellonian Univ, Med Coll, Dept Med Educ, Krakow, Poland
[6] Lodz Med Univ, Div Physiotherapy, Fac Mil Med, Lodz, Poland
[7] St Raphael Hosp, Dept Surg, Krakow, Poland
[8] European Org Res & Treatment Canc Headquarters, Qual Life Dept, Brussels, Belgium
[9] Ignatianum Acad, Fac Educ, Dept Gerontol Geriatr & Social Work, Hlth Outcomes Res Unit, 26 Kopernika St, PL-31501 Krakow, Poland
关键词
Colorectal cancer; EORTC; Hepatectomy; Liver metastasis; QLQ-C30; QLQ-LMC21; Quality of life; Validation; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; QUESTIONNAIRE; TRANSLATION; QLQ-C30; ISSUES; WOMEN;
D O I
10.1016/j.ejon.2017.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This validation study was designed to assess the psychometric validity and quality of the Polish translation of the EORTC QLQ-LMC21 questionnaire in Polish colorectal patients suffering with liver metastases. Methods: Patients with either histopathological or imaging confirmation of colorectal cancer with liver metastases, with a minimum of three months survival, were eligible for this study. These patients completed the Polish version of the EORTC core QLQ-C30, the QLQ-LMC21 module, and a demographic data questionnaire. The questionnaires were completed twice, once before undergoing either hepatectomy (n = 63) or palliative treatment (n = 97) and three months after the primary treatment. Standardized analyses of validity and reliability were performed. Results: One hundred and sixty patients were enrolled in this study with the mean age of the hepatectomy group 64.3 14.1 and 66.1 +/- 12.7 for the palliative treatment group. The QLQ-LMC21 exhibited positive internal consistency with Cronbach's alpha coefficients ranging from 0.72 to 0.90. The multi-trait scaling analysis demonstrated adequate convergent and discriminant validity. Test-retest reliability was undertaken with 40 patients (25%) with the ICCs for each item ranging from 0.64 to 0.88. The hepatectomy group had a significantly greater Karnofsky Performance Score than the palliative treatment group (p.<0.001). Overall there were weak correlations between the two questionnaires which confirm that the QLQ-LMC21 addresses health issues not assessed in the QLQ-C30. Conclusion: The Polish version of the QLQ-LMC21 proved to be a valid and reliable questionnaire to use in conjunction with the QLQ-C30 core questionnaire. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 23 条
  • [1] Translation and psychometric validity of the Brazilian version of the European Organisation for Research and Treatment of Cancer-colorectal liver metastases module
    Tomim, Dabna Hellen
    Lenhani, Bruna Eloise
    Nogueira, Luciana de Alcantara
    Vogt, Tatiele Naiara
    Silva, Leonel dos Santos
    Mantovani, Maria de Fatima
    Bittencourt Guimaraes, Paulo Ricardo
    Kalinke, Luciana Puchalski
    ECANCERMEDICALSCIENCE, 2022, 16
  • [2] Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases
    Blazeby, J. M.
    Fayers, P.
    Conroy, T.
    Sezer, O.
    Ramage, J.
    Rees, M.
    BRITISH JOURNAL OF SURGERY, 2009, 96 (03) : 291 - 298
  • [3] Creation of the Polish version and adaptation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (QLQ-EN24)
    Stukan, Maciej
    Zalewski, Kamil
    Grabowski, Jacek P.
    Mardas, Marcin
    Jones, Steven
    Pietrzak-Stukan, Malgorzata
    Dudziak, Miroslaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (02): : 134 - 139
  • [4] International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34
    Singer, Susanne
    Al-Ibraheem, Akram
    Pinto, Monica
    Iakovou, Ioannis
    Osthus, Arild Andre
    Hammerlid, Eva
    Locati, Laura Deborah
    Gamper, Eva
    Ignacio, Juan J.
    Jordan, Susan
    Kiyota, Naomi
    Buettner, Matthias
    Engesser, Deborah
    Canotilho, Rita
    Ioannidis, Georgios
    Husson, Olga
    Gama, Ricardo Ribeiro
    Fanetti, Giuseppe
    Moss, Laura
    Inhestern, Johanna
    Andry, Guy
    Fuehrer, Dagmar
    Kulis, Dagmara
    Rimmele, Harald
    Sykiotis, Gerasimos
    EORTC Quality Life Grp
    EORTC Head Neck Canc Grp
    EORTC Endocrine Tumours Grp
    THYROID, 2023, 33 (09) : 1078 - 1089
  • [5] International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
    Singer, Susanne
    Amdal, Cecilie Delphin
    Hammerlid, Eva
    Tomaszewska, Iwona M.
    Silva, Joaquim Castro
    Mehanna, Hisham
    Santos, Marcos
    Inhestern, Johanna
    Brannan, Christine
    Yarom, Noam
    Fullerton, Amy
    Pinto, Monica
    Arraras, Juan I.
    Kiyota, Naomi
    Bonomo, Pierluigi
    Sherman, Allen C.
    Baumann, Ingo
    Galalae, Razvan
    Fernandez Gonzalez, Loreto
    Nicolatou-Galitis, Ourania
    Abdel-Hafeez, Zeinab
    Raber-Durlacher, Judith
    Schmalz, Claudia
    Zotti, Paola
    Boehm, Andreas
    Hofmeister, Dirk
    Trivic, Sanja Krejovic
    Loo, Suat
    Chie, Wei-Chu
    Bjordal, Kristin
    Herlofson, Bente Brokstad
    Gregoire, Vincent
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1725 - 1737
  • [6] Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool
    Zahid, Nida
    Martins, Russell Seth
    Zahid, Wajeeha
    Azam, Iqbal
    Ikram, Mubasher
    Hassan, Aneesa
    Bhamani, Shireen Shehzad
    Jabbar, Adnan Abdul
    Asad, Nargis
    Akhtar, Shabbir
    Siddiqui, Moghira Iqbaluddin
    Awan, Mohammad Sohail
    Ahmad, Khabir
    BMC PSYCHOLOGY, 2022, 10 (01)
  • [7] Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)
    Greimel, Elfriede
    Nordin, Andy
    Lanceley, Anne
    Creutzberg, Carien L.
    van de Poll-Franse, Lonneke V.
    Radisic, Vesna Bjelic
    Galalae, Razvan
    Schmalz, Claudia
    Barlow, Ellen
    Jensen, Pernille T.
    Waldenstrom, Ann-Charlotte
    Bergmark, Karin
    Chie, Wei-Chu
    Kuljanic, Karin
    Costantini, Anna
    Singer, Susanne
    Koensgen, Dominique
    Menon, Usha
    Daghofer, Fedor
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) : 183 - 190
  • [8] The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22
    Chow, Edward
    Hird, Amanda
    Velikova, Galina
    Johnson, Colin
    Dewolf, Linda
    Bezjak, Andrea
    Wu, Jackson
    Shafiq, Jesmin
    Sezer, Orhan
    Kardamakis, Dimitrios
    van der Linden, Yvette
    Ma, Brigette
    Castro, Monica
    Foro Arnalot, Palmira
    Ahmedzai, Sam
    Clemons, Mark
    Hoskin, Peter
    Yee, Albert
    Brundaye, Michael
    Bottomley, Andrew
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (07) : 1146 - 1152
  • [9] Validation of the Korean version of the European Organization for Research and Treatment of Cancer brain cancer module (EORTC QLQ-BN20) in patients with brain tumors
    Shin, Yong Soon
    Kim, Jeong Hoon
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [10] The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
    Singer, Susanne
    Hammerlid, Eva
    Tomaszewska, Iwona M.
    Amdal, Cecilie D.
    Herlofson, Bente B.
    Santos, Marcos
    Silva, Joaquim Castro
    Mehanna, Hisham
    Fullerton, Amy
    Young, Teresa
    Gonzalez, Loreto Fernandez
    Inhestern, Johanna
    Pinto, Monica
    Arraras, Juan I.
    Yarom, Noam
    Bonomo, Pierluigi
    Baumann, Ingo
    Galalae, Razvan
    Nicolatou-Galitis, Ourania
    Kiyota, Naomi
    Raber-Durlacher, Judith
    Salem, Dina
    Fabian, Alexander
    Boehm, Andreas
    Krejovic-Trivic, Sanja
    Chie, Wei-Chu
    Taylor, Katherine J.
    Sherman, Allen C.
    Licitra, Lisa
    Machiels, Jean-Pascal
    Bjordal, Kristin
    EUROPEAN JOURNAL OF CANCER, 2024, 212